Theresa Marie LAVALLEE,Carolyn Fowler SIDOR,Diego ALVARADO
申请号:
US16111724
公开号:
US20180362443A1
申请日:
2018.08.24
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Provided herein are methods of treating cancer comprising administering antibodies and antigen-binding fragments thereof that bind the extracellular domain of the HER3 receptor and inhibit various HER3 receptor related functions via ligand-dependent and/or ligand-independent mechanisms, and dosing regimens for related monotherapies and combination therapies.